← Back
Data updated: Mar 10, 2026
JAZZ PHARMS THERAP
Oncology
JAZZ PHARMS THERAP is a pharmaceutical company focused on Oncology. Key products include VYXEOS.
2017
Since
1
Drugs
-
Trials
1
Approved (2yr)
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2017-08-03
- Latest
- 2026-01-27
- Applications
- 1